Table 2.

Angiographic and clinical outcomes.

	FD group	Conventional stents group	Significance (P-Value)
Complication, n(%)	3 (15%)	1 (6.3%)	0.613
Clinical follow-up time (Mean, months)	42.1	51.3	0.063
MRI follow-up time (Mean, months)	24.4	24.7	0.958
Angiographic follow-up time (Mean, months)	9.7	14.3	0.198
Treatment modality, n(%)			0.041
Stents alone	13 (65%)	4 (25%)
Stents with coils	7 (35%)	12 (75%)
Number of stents implanted, n(%)
1	17 (85%)	5 (31.3%)	0.002
2	2 (10%)	6 (37.5%)	0.103
3	1 (5%)	5 (31.3%)	0.069
Immediate angiographic	20	16	0.004
Favorable results, n(%)	2 (15%)	10 (66.7%)
Unfavorable results, n(%)	17 (85%)	5 (33.3%)
Last angiographic	15	14	0.390
Favorable results, n(%)	13 (86.7%)	10 (71.4%)
Unfavorable results, n(%)	2 (13.3%)	4 (28.6%)
Recurrence, n(%)	0 (0%)	5 (31.3)	0.044
Change of IMH size, n(%)	−2.7%	8.1%	0.036
Follow-up of clinical outcome	20	16	0.637
Favorable results, n(%)	18 (90%)	13 (81.3%)
Unfavorable results, n(%)	2 (10%)	3 (18.8%)
Change in mRS score, n(%)
Improved	12 (60%)	4 (25%)	0.036
No change	6 (30%)	8 (50%)	0.307
Worsened	2 (10%)	4 (25%)	0.374

FD, flow diverter; IMH, intramural hematoma; mRS, modified Rankin scale.

Boldface type indicates statistical significance.